Concepedia

Publication | Open Access

Phase 3 CLEAR study in patients with advanced renal cell carcinoma: outcomes in subgroups for the lenvatinib-plus-pembrolizumab and sunitinib arms

DOIFull Paper Access

37

Citations

15

References

2023

Year

Viktor Grünwald, Thomas Powles, Masatoshi Eto, Evgeny Kopyltsov, Sun Young Rha, Camillo Porta, Robert J. Motzer, Thomas E. Hutson, María José Méndez-Vidal, Sung‐Hoo Hong,
Frontiers in Oncology

Abstract

ClinicalTrials.gov, identifier NCT02811861.

References

YearCitations

Page 1